American Psychiatrists Reveal Changing Attitudes About the Therapeutic Use of Classic Hallucinogens
Consult QD
DECEMBER 11, 2023
Despite accelerating research on the therapeutic potential of classic hallucinogens (or ‘‘classic psychedelics’’), relatively little is known about how these compounds are viewed by American psychiatrists. Designed to capture evolving attitudes toward psychoactive drugs like psilocybin, lysergic acid (LSD) and mescaline, a new study reveals a distinctively positive shift in how hallucinogens are perceived by the psychiatric community.
Let's personalize your content